Private equity in healthcare saw its second highest year on record in 2022, closing on roughly $90 billion worth of deals, according to a report from consulting from Bain and Co.
Despite a slowdown caused by macro-economic and geopolitical forces in the second half of the year, 2022 was still the second-best year on record for healthcare dealmaking, due in large part to the white-hot pace of investment at the start of the year, according to the report.
Total disclosed deal value reached nearly $90 billion, down from $151 billion in 2021 but still more than $10 billion more than the next-closest year, Healthcare Finance reports. Bain’s new report shows that ample capital in reserve and a track record of returns will continue to attract healthcare-specific funds in 2023.
“Healthcare private equity has earned a recession-proof reputation, typically outperforming overall private equity activity during economic downturns,” said Kara Murphy, co-lead of Healthcare Private Equity at Bain. Read more.
